Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Nyxoah ( (NYXH) ).
Nyxoah disclosed a new transparency notification under Belgian shareholding rules, indicating that founder Robert Taub and related entity Robelga SRL together control 4,360,800 voting rights, or 10.14% of the company as of December 30, 2025. The filing shows Robelga SRL crossed the 3% ownership threshold without changing the group’s overall stake, clarifying the internal structure of Taub’s holding and signaling stable, significant insider ownership for existing shareholders.
According to the notification, Taub and his controlled entities hold 4,310,800 voting rights attached to securities and 50,000 potential voting rights via subscription rights maturing in 2027 and 2028. The disclosure, triggered by Robelga SRL’s increased stake, enhances transparency around Nyxoah’s shareholder base and may be interpreted by the market as evidence of continued long-term commitment from a key insider and his family-controlled entities.
The most recent analyst rating on (NYXH) stock is a Buy with a EUR9.00 price target. To see the full list of analyst forecasts on Nyxoah stock, see the NYXH Stock Forecast page.
More about Nyxoah
Nyxoah SA is a Belgium-based medical technology company listed on Euronext Brussels and Nasdaq under the symbol NYXH. The company focuses on therapies for sleep-disordered breathing, developing and commercializing implantable solutions to treat obstructive sleep apnea in international markets.
Average Trading Volume: 64,761
Current Market Cap: €115.9M
For an in-depth examination of NYXH stock, go to TipRanks’ Overview page.